Prevalence of Adherence to Finasteride Treatment in Patients with Benign Prostatic Hyperplasia from a Urology Service of the I.S.S.S.T.E.
December 2008
New to Finasteride? There is a guide in the encyclopedia. Read the guide → Studysummary This study observed that adherence to finasteride treatment in patients with benign prostatic hyperplasia at a clinic in Tepic Nayarit had not been previously evaluated in Mexico.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study aimed to determine the frequency of adherence to finasteride treatment in 139 male patients with benign prostatic hyperplasia (BPH) at the I.S.S.S.T.E. Clinic in Tepic Nayarit, Mexico, during 2007. Adherence to medical treatments, particularly for chronic conditions, was generally low, with developed countries seeing around 50% adherence. The study used a structured questionnaire and visual analogue scale to assess adherence over 2 to 6 months. The research highlighted the importance of adherence to finasteride in reducing prostate cancer risk, though specific adherence rates in this study were not detailed.
